Opioid peptides in cancer

Cancer and Metastasis Reviews

Volumn 23, Issue 3-4, 2004, Pages 351-366

  Fichna, Jakub ^a   Janecka, Anna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

carcinogenesis; carcinoma; opioid peptide analogs; opioid peptides; opioid receptors

Indexed keywords

AMINO ACID DERIVATIVE; BETA ENDORPHIN; CASEIN; DYNORPHIN DERIVATIVE; ENKEPHALIN DERIVATIVE; GLUTEN; HEMOGLOBIN; LEUMORPHIN; LIGAND; OPIATE; PEPTIDE DERIVATIVE; PEPTIDE E; PEPTIDE F; PROTEIN DERIVATIVE; SPINORPHIN;

BREAST CANCER; CANCER CELL; CARCINOGENESIS; CELL CYCLE; COLON CANCER; DNA SYNTHESIS; ENDOMETRIUM CARCINOMA; GLIOMA; HUMAN; IMMUNOREACTIVITY; LUNG CANCER; MELANOMA; MOLECULAR CLONING; MOLECULAR MECHANICS; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; HUMANS; NEOPLASMS; OPIOID PEPTIDES; RECEPTORS, OPIOID; SIGNAL TRANSDUCTION;

EID: 3042736844     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CANC.0000031773.46458.63     Document Type: Review

References (105)

1. Hollt V: Opioid peptide processing and receptor selectivity. Annu Rev Pharmacol Toxicol 26: 59-77, 1986
2. Margioris AN, Liotta AS, Vaudry H, Bardin CW, Krieger DT: Characterization of immunoreactive proopiomelanocortin-related peptides in rat testes. Endocrinology 113: 663-671, 1983
3. Douglass J, Cox B, Quinn B, Civelli O, Herbert E: Expression of the prodynorphin gene in male and female mammalian reproductive tissues. Endocrinology 120: 707-713, 1987
4. Castanas E, Giraud P, Audigier Y, Drissi R, Boudouresque F, Conte-Devolx B, Oliver C: Opiate binding sites spectrum on bovine adrenal medullas and six human pheochromocytomas. Life Sci 33(Suppl 1): 295-298, 1983
5. Giraud P, Castanas E, Oliver C, Conte-Devolx B, Boudouresque F, Taquet H, Orlando M, Jaquet P, Eiden L, Cesselin F, Gunz G, Trigano M: Enkephalins in human pheochromocytoma biosynthesis and secretion. Eur Heart J 3(Suppl C): 19-22, 1982
6. Roy S, Loh HH: Effects of opioids on the immune system. Neurochem Res 21: 1375-1386, 1996
7. Scharrer B, Stefano GB: Neuropeptides and immunoregulation. In Neuropeptides and Immunoregulation. Springer Verlag, Berlin, 1994
8. Stefano GB, Scharrer B, Smith EM, Hughes TK Jr., Magazine HI, Bilfinger TV, Hartman AR, Fricchione GL, Liu Y, Makman MH: Opioid and opiate immunoregulatory processes. Crit Rev Immunol 16: 109-144, 1996
9. McLaughlin PJ: Opioid antagonist modulation of rat heart development. Life Sci 54: 1423-1431, 1994
10. Zagon IS, McLaughlin PJ: The role of endogenous opioids and opioid receptors in human and animal cancers. In Stress and Immunity. Plotnikoff NP, Murgo AJ, Faith RE, Wybran J, eds. CRC, Caldwell NJ, 343-356, 1991
11. Zagon IS, McLaughlin PJ: Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system. Brain Res 542: 318-323, 1991
12. Zagon IS, McLaughlin PJ: Receptors in the developing nervous system, Volume 1. Growth factors and hormones. Chapman and Hall, London, 39-62, 1993
13. Zagon IS, Wu Y, McLaughlin PJ: Opioid growth factor inhibits DNA synthesis in mouse tongue epithelium in a circadian rhythm-dependent manner. Am J Physiol 267(3 Pt 2): R645-R652, 1994
14. Nyberg F, Sanderson K, Glamsta EL: The hemorphins: A new class of opioid peptides derived from the blood protein hemoglobin. Biopolymers 43: 147-156, 1997
15. Zhao Q, Garreau I, Sannier F, Piot JM: Opioid peptides derived from hemoglobin: Hemorphins. Biopolymers 43: 75-98, 1997
16. Zioudrou C, Streaty RA, Klee WA: Opioid peptides derived from food proteins. The exorphins. J Biol Chem 254: 2446-2449, 1979
17. Brantl V, Teschemacher H, Henschen A, Lottspeich F: Novel opioid peptides derived from casein (beta-casomorphins). I. Isolation from bovine casein peptone. Hoppe Seylers Z Physiol Chem 360: 1211-1216, 1979
18. Meisel H: Biochemical properties of regulatory peptides derived from milk proteins. Biopolymers 43: 119-128, 1997
19. Kampa M, Loukas S, Hatzoglou A, Martin P, Martin PM, Castanas E: Identification of a novel opioid peptide (Tyr-Val-Pro-Phe-Pro) derived from human alpha S1 casein (alpha S1-casomorphin and alpha S1-casomorphin amide). Biochem J 319(Pt 3): 903-908, 1996
20. Kampa M, Bakogeorgou E, Hatzoglou A, Damianaki A, Martin PM, Castanas E: Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors. Eur J Pharmacol 335: 255-265, 1997
21. Raynor K, Kong H, Law S, Heerding J, Tallent M, Livingston F, Hines J, Reisine T: Molecular biology of opioid receptors. NIDA Res Monogr 161: 83-103, 1996
22. Reisine T, Bell GI: Molecular biology of opioid receptors. Trends Neurosci 16: 506-510, 1993
23. Castanas E, Bourhim N, Giraud P, Boudouresque F, Cantau P, Oliver C: Interaction of opiates with opioid binding sites in the bovine adrenal medulla: I. Interaction with delta and mu sites. J Neurochem 45: 677-687, 1985
24. Castanas E, Bourhim N, Giraud P, Boudouresque F, Cantau P, Oliver C: Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites. J Neurochem 45: 688-699, 1985
25. Reisine T, Law SF, Blake A, Tallent M: Molecular mechanisms of opiate receptor coupling to G proteins and effector systems. Ann NY Acad Sci 780: 168-175, 1996
26. Lundberg JM, Hamberger B, Schultzberg M, Hokfelt T, Granberg PO, Efendic S, Terenius L, Goldstein M, Luft R: Enkephalin- and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma. Proc Natl Acad Sci USA 76: 4079-4083, 1979
27. Zagon IS, McLaughlin PJ, Goodman SR, Rhodes RE: Opioid receptors and endogenous opioids in diverse human and animal cancers. J Natl Cancer Inst 79: 1059-1065, 1987
28. Roth KA, Bensch KG, Hoffman AR: Characterization of opioid peptides in human thyroid medullary carcinoma. Cancer 59: 1594-1598, 1987
29. Bostwick DG, Null WE, Holmes D, Weber E, Barchas JD, Bensch KG: Expression of opioid peptides in tumors. N Engl J Med. 317: 1439-1143, 1987
30. Scholar EM, Violi L, Hexum TD: The antimetastatic activity of enkephalin-like peptides. Cancer Lett 35: 133-138, 1987
31. Kita T, Kikuchi Y, Oomori K, Nagata I: Effects of opioid peptides on the tumoricidal activity of spleen cells from nude mice with or without tumors. Cancer Detect Prev 16: 211-214, 1992
32. Scopsi L, Balslev E, Brunner N, Poulsen HS, Andersen J, Rank F, Larsson LI: Immunoreactive opioid peptides in human breast cancer. Am J Pathol 134: 473-479, 1989
33. Cerpa-Poljak A, Lahnstein J, Mason KE, Smythe GA, Duncan MW: Mass spectrometric identification and quantification of hemorphins extracted from human adrenal and pheochromocytoma tissue. J Neurochem 68: 1712-1719, 1997
34. Reubi JC: Central nervous system-mediated growth inhibition of a rat prostate carcinoma by an opioid. J Endocrinol 107: 247-250, 1985
35. Hatzoglou A, Bakogeorgou E, Castanas E: The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Eur J Pharmacol 296: 199-207, 1996
36. Maneckjee R, Biswas R, Vonderhaar BK: Binding of opioids to human MCF-7 breast cancer cells and their effects on growth. Cancer Res 50: 2234-2238, 1990
37. Hytrek SD, Smith JP, McGarrity TJ, McLaughlin PJ, Lang CM, Zagon IS: Identification and characterization of zeta-opioid receptor in human colon cancer. Am J Physiol 271(1 Pt 2): R115-R121, 1996
38. Hatzoglou A, Gravanis A, Margioris AN, Zoumakis E, Castanas E: Identification and characterization of opioid binding sites present in the Ishikawa human endometrial adenocarcinoma cell line. J Clin Endocrinol Metab 80: 418-423, 1995
39. Chatikhine VA, Chevrier A, Chauzy C, Duval C, d'Anjou J, Girard N, Delpech B: Expression of opioid peptides in cells and stroma of human breast cancer and adenofibromas. Cancer Lett 77: 51-56, 1994
40. Francois A, Chatikhine VA, Chevallier B, Ren GS, Berry M, Chevrier A, Delpech B: Neuroendocrine primary small cell carcinoma of the breast. Report of a case and review of the literature. Am J Clin Oncol 18: 133-138, 1995
41. Ferri GL, Watkinson A, Dockray GJ: Proenkephalin A-derived peptides in the human gut. Gastroenterology 95: 1011-1017, 1988
42. Zagon IS, Hytrek SD, McLaughlin PJ: Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture. Am J Physiol 271: R511-R518, 1996
43. Yoshimasa T, Nakao K, Ikeda Y, Sakamoto M, Suda M, Imura H: Methionine-enkephalin, leucine-enkephalin methionine-enkephalin-Arg6-Phe7 and methionine-enkephalin-Arg6-Gly7-Leu8 in human pheochromocytoma. Life Sci 33(Suppl 1): 85-88, 1983
44. Suda T, Tozawa F, Tachibana S, Demura H, Shizume K, Sasaki A, Mouri T, Miura Y: Multiple forms of immunoreactive dynorphin in human pituitary and pheochromocytoma. Life Sci 32: 865-870, 1983
45. Yoshimasa T, Nakao K, Oki S, Tanaka I, Nakai Y, Imura H: Presence of dynorphin-like immunoreactivity in pheochromocytomas. J Clin Endocrinol Metab 53: 213-214, 1981
46. Deftos LJ, Bone HG 3rd, Parthemore JG: Immunohistological studies of medullary thyroid carcinoma and C cell hyperplasia. J Clin Endocrinol Metab 51: 857-862, 1980
47. Steenbergh PH, Hoppener JWM, Zandberg J, Roos BA, Jansy HS, Lips CJM: Expression of the pro-opiomelanocrtin gene in human medullary thyroid carcinoma. J Clin Endocrinol Metab 58: 904-908, 1984
48. Gillies G, Ratter S, Grossman A, Gaillard R, Lowry PJ, Besser GM, Rees LH: Secretion of ACTH, LPH and beta-endophin from human pituitary tumors in vitro. Clin Endocrinol (Oxf) 13: 197-205, 1980
49. Suda T, Tozawa F, Yamaguchi H, Shibasaki T, Demura H, Shizume K: Multiple forms of immunoreactive beta-endorphin are present in an ectopic adrenocorticotropin-producing tumor but not in normal pituitary or pituitary adenomas. J Clin Endocrinol Metab 54: 167-171, 1982
50. Pullan PT, Clement-Jones V, Corder R, Lowry PJ, Rees GM, Rees LH, Besser GM, Macedo MM, Galvao-Teles A: Ectopic production of methionine enkephalin and beta-endorphin. Br Med J 280: 758-759, 1980
51. Pullman PT, Clement-Jones V, Corder R, Lowry PJ, Besser GM, Rees LH: ACTH LPH and related peptides in the ectopic ACTH syndrome. Clin Endocrinol (Oxf) 13: 437-445, 1980
52. Makrigiannakis A, Margioris A, Markogiannakis E, Stournaras C, Gravanis A: Steroid hormones regulate the release of immunoreactive beta-endorphin from the Ishikawa human endometrial cell line. J Clin Endocrinol Metab 75: 584-589, 1992
53. Barg J, Belcheva MM, Bem WT, Lambourne B, McLachlan JA, Tolman KC, Johnson FE, Coscia CJ: Desipramine modulation of sigma and opioid peptide receptor expression in glial cells. Peptides 12: 845-849, 1991
54. Barg J, Belcheva MM, Levy R, McHale RJ, McLachlan JA, Johnson FE, Coscia CJ, Vogel Z: A monoclonal anti-idiotypic antibody to opioid receptors labels desipramine-induced opioid binding sites on rat C6 glioma cells and attenuates thymidine incorporation into DNA. Glia 10: 10-15, 1994
55. Reggiani A, Carenzi A, Della Bella D: Influence of opioids on beta-receptor down-regulation: Studies in cultured C6 glioma cells. Brain Res 423: 254-260, 1987
56. Bohn LM, Belcheva MM, Coscia CJ: Evidence for kappa and mu-opioid receptor expression in C6 glioma cells. J Neurochem 70: 1819-1825, 1998
57. Roth KA, Barchas JD: Small cell carcinoma cell lines contain opioid peptides and receptors. Cancer 57: 769-773, 1986
58. Maneckjee R, Minna JD: Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc Natl Acad Sci USA 87: 3294-3298, 1990
59. Campa MJ, Schreiber G, Bepler G, Bishop MJ, McNutt RW, Chang KJ, Patz EF Jr.: Characterization of delta opioid receptors in lung cancer using a novel nonpeptidic ligand. Cancer Res 56: 1695-1701, 1996
60. Slominski A, Paus R, Wortsman J: On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol 93: C1-6, 1993
61. Nagahama M, Funasaka Y, Fernandez-Frez ML, Ohashi A, Chakraborty AK, Ueda M, Ichihashi M: Immunoreactivity of alfa-melanocyte-stimulating hormone, adrenocorticotrophic hormone and beta-endorphin in cutaneous malignantg melanoma and benign melanocytic naevi. Br J Dermatol 138: 981-985, 1998
62. Krieger DT, Margioris AN, Liotta AS: Pro-opiomelanocortin-derived peptides in the rodent male reproductive tract. In Delitala G, Motta M, Serio M (eds) Opioid Modulation of Endocrine Function. Raven Press, New York NY, 1984, pp. 223-235
63. Tainio H: Peptidergic innervation of the human prostate, seminal vesicle and vas deferens. Acta Histochem 97: 113-119, 1995
64. Bartolome JV, Bartolome MB, Lorber BA, Dileo SJ, Schanberg SM: Effects of central administration of beta-endorphin on brain and liver DNA synthesis in preweanling rats. Neuroscience 40: 289-294, 1991
65. McLaughlin PJ: Regulation of DNA synthesis of myocardial and epicardial cells in developing rat heart by [Met5]enkephalin. Am J Physiol 271(1 Pt 2): R122-R129, 1996
66. Murgo AJ: Inhibition of B16-BL6 melanoma growth in mice by methionine-enkephalin. J Natl Cancer Inst 75: 341-344, 1985
67. Shahabi NA, Sharp BM: Antiproliferative effects of delta opioids on highly purified CD4+ and CD8+ murine T cells. J Pharmacol Exp Ther 273: 1105-1113, 1995
68. Hatzoglou A, Bakogeorgou E, Papakonstanti E, Stournaras C, Emmanouel DS, Castanas E: Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth. J Cell Biochem 63: 410-421, 1996
69. Panagiotou S, Hatzoglou A, Calvo F, Martin PM, Castanas E: Modulation of the estrogen-regulated proteins cathepsin D and pS2 by opioid agonists in hormone-sensitive breast cancer cell lines (MCF7 and T47D): Evidence for an interaction between the two systems. J Cell Biochem 71: 416-428, 1998
70. Panagiotou S, Bakogeorgou E, Papakonstanti E, Hatzoglou A, Wallet F, Dussert C, Stournaras C, Martin PM, Castanas E: Opioid agonists modify breast cancer cell proliferation by blocking cells to the G2/M phase of the cycle: Involvement of cytoskeletal elements. J Cell Biochem 73: 204-211, 1999
71. Rivier C, Vale W, Ling N, Brown M, Guillemin R: Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin. Endocrinology 100: 238-241, 1977
72. Johnson HM, Smith EM, Torres BA, Blalock JE: Regulation of the in vitro antibody response by neuroendocrine hormones. Proc Natl Acad Sci USA 79: 4171-4174, 1982
73. Blalock JE: Proopiomelanocortin-derived peptides in the immune system. Clin Endocrinol (Oxf) 22: 823-827, 1985
74. Moon TD: The effect of opiates upon prostatic carcinoma cell growth. Biochem Biophys Res Commun 153: 722-727, 1988
75. Lee YS, Wurster RD: Differential effects of methionine enkephalin on the growth of brain tumor cells. J Neurooncol 19: 11-15, 1994
76. Woll PJ: Neuropeptide growth factors and cancer. Br J Cancer 63: 469-475, 1991
77. Iishi H, Tatsuta M, Baba M, Okuda S, Taniguchi H: Enhancement by methionine enkephalin of colon carcinogenesis induced by azoxymethane. Cancer Res 51: 785-788, 1991
78. Lantz I, Glamsta EL, Talback L, Nyberg F: Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity. FEBS Lett 287: 39-41, 1991
79. Zhao Q, Saunier F, Garreau I, Guillochon D, Piot JM: Inhibition and inhibition kinetics of angiotensin converting enzyme activity by hemorphins, isolated from a peptic bovine hemoglobin hydrolysate. Biochem Biophys Res Commun 204: 216-223, 1994
80. Bunn PA Jr., Chan D, Dienhart DG, Tolley R, Tagawa M, Jewett PB: Neuropeptide signal transduction in lung cancer: Clinical implications of bradykinin sensitivity and overall heterogeneity. Cancer Res 52: 24-31, 1992
81. Leslie FM: Methods used for the study of opioid receptors. Pharmacol Rev 39: 197-249, 1987
82. Zagon IS, Sassani JW, Allison G, McLaughlin PJ: Conserved expression of the opioid growth factor, [Met5]enkephalin, and the zeta (zeta) opioid receptor in vertebrate cornea. Brain Res 671: 105-111, 1995
83. Zagon IS, Isayama T, McLaughlin PJ: Preproenkephalin mRNA expression in the developing and adult rat brain. Brain Res Mol Brain Res 21: 85-98, 1994
84. Isayama T, McLaughlin PJ, Zagon IS: Endogenous opioids regulate cell proliferation in the retina of developing rat. Brain Res 544: 79-85, 1991
85. Zagon IS, McLaughlin P: Endogenous opioids and the growth regulation of a neural tumor. Life Sci 43: 1313-1318, 1988
86. Zagon IS, McLaughlin PJ: Endogenous opioid systems regulate growth of neural tumor cells in culture. Brain Res 490: 14-25, 1989
87. Plotnikoff NP, Miller GC: Enkephalins as immunomodulators. Int J Immunopharmacol 5: 437-441, 1983
88. Jankovic BD, Maric D: Enkephalins and immunity. I: In vivo suppression and potentiation of humoral immune response. Ann N Y Acad Sci 496: 115-125, 1987
89. Maric D, Jankovic BD: Enkephalins and immunity. II: In vivo modulation of cell-mediated immunity. Ann N Y Acad Sci 496: 126-136, 1987
90. Zagon IS, Roesener CD, Verderame MF, Ohlsson-Wilhelm BM, Levin RJ, McLaughlin PJ: Opioid growth factor regulates the cell cycle of human neoplasias. Int J Oncol 17: 1053-1061, 2000
91. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996
92. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 266: 1821-1828, 1994
93. Shackney SE, Shackney TV: Cell cycle models for molecular biology and molecular oncology: Exploring new dimensions. Cytometry 35: 97-116, 1999
94. Pardee AB: G1 events and regulation of cell proliferation. Science 246: 603-608, 1989
95. Zagon IS, Verderame MF, Allen SS, McLaughlin PJ: Cloning, sequencing, chromosomal location, and function of cDNAs encoding an opioid growth factor receptor (OGFr) in humans. Brain Res 856: 75-83, 2000
96. Zagon IS, Verderame MF, Zimmer WE, McLaughlin PJ: Molecular characterization and distribution of the opioid growth factor receptor (OGFr) in mouse. Brain Res Mol Brain Res 84: 106-114, 2000
97. Zagon IS, Hytrek SD, Lang CM, Smith JP, McGarrity TJ, Wu Y, McLaughlin PJ: Opioid growth factor ([Met5]enkephalin) prevents the incidence and retards the growth of human colon cancer. Am J Physiol 271(3 Pt 2): R780-R786, 1996
98. Zagon IS, Verderame MF, McLaughlin PJ: The biology of the opioid growth factor receptor (OGFr). Brain Res Brain Res Rev 38: 351-376, 2002
99. Yoshimasa T, Nakao K, Ohtsuki H, Li S, Imura H: Methionine-enkephalin and leucine-enkephalin in human sympathoadrenal system and pheochromocytoma. J Clin Invest 69: 643-650, 1982
100. Crowe R, Chapple CR, Burnstock G: The human prostate gland: A histochemical and immunohistochemical study of neuropeptides, serotonine, dopamine beta-hydroxylase and acetylcholinesterase in autonomic nerves ganglia. Br J Urol 68: 53-61, 1991
101. Noordzij MA, van Steenbrugge GJ, van der Kwast TH, Schroder FH: Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate. Urol Res 22: 333-341, 1995
102. Gkonos PJ, Krongrad A, Roos BA: Neuroendocrine peptides in the prostate. Urol Res 23: 81-87, 1995
103. VonHoff DD, Forseth B: Modulation of growth of human and murine humors by human beta-endorphin (beta-END). Abstract 932. Proc Am Assoc Cancer Res 236, 1982
104. Kampa M, Loukas S, Tsapis A, Castanas E: Receptorphin: A conserved peptide derived from the sequence of the opioid receptor, with opioid displacement activity and potent antiproliferative actions in tumor cells. BMC Pharmacol 1: 9, 2001
105. Hatzoglou A, Bakogeorgou E, Hatzoglou C, Martin PM, Castanas E: Antiproliferative and receptor binding properties of alfa- and beta-casomorphins in the T47D human breast cancer cell line. Eur J Pharmacol 310: 217-223, 1996